Background: The ability to predict the severity of disease is important to reduce morbidity and mortality in patients with acute pancreatitis (AP). Vitamin D deficiency has been associated with severity in various diseases. Objective: This study was conducted to assess vitamin D as a predictor of disease severity in patients with AP. Methods: Patients with AP were prospectively enrolled at Yonsei University Wonju College of Medicine from March 2015 to September 2017. Serum vitamin D was analyzed as soon as AP was diagnosed. The level of vitamin D was classified as normal (>20 ng/ml), insufficient (>10 and 20 ng/ml) or deficient ( 10 ng/ml). Results: Among 242 patients with AP, the prevalence of vitamin D deficiency was 56.2%, and 28.5% of patients had vitamin D insufficiency. Serum vitamin D level was negatively correlated with severity indexes, such as the Atlanta classification, Computed Tomography Severity Index, Bedside Index for Severity of Acute Pancreatitis, and Ranson score. The prevalence of vitamin D deficiency increased with severity of AP according to the Atlanta classification. Vitamin D deficiency was the independent factor for predicting severe AP (OR 5.37, 95% CI 1.13-25.57, p ¼ 0.015) and intensive care unit admission (OR 3.09, 95% CI 1.24-7.69, p ¼ 0.035). Conclusion: Vitamin D deficiency is associated with increased severity of AP and is a predictor for intensive care unit admission.
Introduction
Acute pancreatitis (AP) is an inflammatory process that causes local and systemic inflammatory response syndrome. The incidence of AP is increasing worldwide, and the disease is associated with high morbidity and mortality. 1, 2 Most patients with AP experience a mild disease course, but 20% of patients develop moderately severe or severe AP (SAP). 1, 3 The mortality due to AP is approximately 13% in patients with sterile necrosis and 15% to 35% in patients with infected necrosis. 3 Therefore, early recognition of the severity of AP is very important to optimize intensive therapy and improve outcomes. 4 Several scoring systems such as Ranson score, Acute Physiology and Chronic Health Examination II (APACHE II) score, computed tomography severity index (CTSI), and Bedside Index for Severity in Acute pancreatitis (BISAP) have been developed to identify the severity of AP. [5] [6] [7] [8] The Atlanta classification was revised in 2012 (Atlanta 2012). 9 In addition, individual underlying comorbidities such as metabolic syndrome and diabetes mellitus were related to the severity of disease. 10, 11 Recent studies have shown that inflammatory markers such as apolipoprotein B/A-I ratio, neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio were related to AP severity. 12, 13 Vitamin D 3 (cholecalciferol) is a secosteroid hormone that affects bone metabolism and also has immunologic properties. Vitamin D insufficiency is common worldwide, and the prevalence of vitamin D insufficiency has been reported to be 47.3% in males and 64.5% in females in Korea. 14, 15 The presence of vitamin D receptors in other tissues and organs suggests that vitamin D physiology extends well beyond bone homeostasis. 16 Vitamin D seems to play a role in chronic inflammatory disease, including cardiovascular diseases, diabetes mellitus, cancer, infections and autoimmune diseases. 17 A few studies have reported the possible role of vitamin D deficiency in chronic and acute pancreatitis. 18 However, there has been no study investigating the relationship between vitamin D deficiency and severity of AP.
In this study, we aimed to determine the prevalence of vitamin D deficiency in patients admitted to a tertiary care center with AP and to assess the severity of AP according to vitamin D level.
Materials and methods

Patients
This was a prospective study of patients with AP in Yonsei University Wonju College of Medicine from March 2015 to September 2017. AP was diagnosed based on the presence of two of the following three features: 9 (1) typical abdominal pain, (2) serum amylase and/or lipase ! 3 times the upper normal limit and (3) radiologic findings. Peripheral blood samples were obtained on admission. Hemoglobin, hematocrit, white blood cell count, calcium, phosphorus, blood urea nitrogen, creatinine, lactate dehydrogenase, aspartate aminotransferase, C-reactive protein (CRP) and arterial blood gas analysis were measured at the time of admission. Hypertension and diabetes mellitus were checked by medical examination and body mass index (BMI) was calculated. Abdominal computed tomography (CT) scan was performed in all patients upon admission to differentiate AP from other diseases. Once AP was diagnosed, scoring systems, such as the Ranson 
Statistical analysis
Categorical variables were presented as the frequency and percentage. Continuous variables were presented as the mean ( AE SD) or median with range. One-way analysis of variance (ANOVA) or chi-squared test was used to compare the scoring systems and number of intensive care unit (ICU) admissions according to serum vitamin D level. The Pearson rank method was used to evaluate the correlation between serum vitamin D level and scoring system. We calculated the odds ratios (ORs) and confidence intervals (CIs) for having SAP and ICU admission using a multivariable logistic regression analysis after adjustment for confounding variables. A p < 0.05 was considered statistically significant. All statistical analysis was performed using SPSS version 21.0 for Windows (SPSS Inc, Chicago, IL, USA).
Results
Study population
A total of 242 patients were enrolled in this study. Table 1 shows the baseline characteristics of all patients. The etiology of AP included gallstones (52.5%), alcohol consumption (36%), hypertriglyceridemia (5%) and idiopathic (6.6%). The number of patients with hypertension and diabetes mellitus was 89 (36.8%) and 69 (28.5%), respectively. The mean BMI was 24.4 AE 4.5 kg/m 2 . According to the Atlanta 2012 classification system, 162 patients (66.9%) were diagnosed with mild AP, 63 (26%) with moderately severe AP, and 17 (7%) with SAP. The median Ranson score was 2 (range, 0-7), median CTSI was 2 (range, 0-8) and median BISAP was 1 (range, 0-5). The median hospital stay was five days (range, 1-57), and the total number of ICU admissions was 36 (14.9%). There were four mortalities (1.7%) among all of the AP patients enrolled in the study. The mean value of CRP was 4.6 AE 6.5 mg/dl. The mean serum level of 25-(OH)D 3 was 11.8 AE 8.2 ng/ml.
Vitamin D level and severity of pancreatitis
The prevalence of vitamin D insufficiency and deficiency in patients with AP were 28.5% and 56.2%, respectively. The severity of AP was classified by scoring systems such as the CTSI, Ranson and BISAP. The prevalence of CTSI greater than 3 and BISAP greater than 3 was significantly higher in the group of patients with vitamin D deficiency ( Table 2 ). The prevalence of vitamin D deficiency was significantly increased with severity of AP according to the Atlanta classification ( Figure 1 ). The number of ICU admissions was high in the group of patients with vitamin D deficiency. The serum level of 25-(OH)D 3 was negatively correlated with the Atlanta classification, CTSI, Ranson score, BISAP and CRP level (Table 3) .
Predictive factors affecting ICU admission and SAP
Initially, we investigated the predictive factors for ICU admission among all patients with AP. In univariate analysis, alcohol, BMI and vitamin D deficiency were related with ICU admission. Vitamin D deficiency was the only independent predictive factor for ICU admission (OR, 3.09; 95% CI, 1.24-7.69; p ¼ 0.015, Table 4 ). Table 5 ).
Discussion
In this study, we evaluated the correlation between 25-(OH)D 3 level and AP severity. Serum 25-(OH)D 3 level was inversely related with the severity of AP as well as inflammatory markers (e.g. CRP). Moreover, we found that lower serum 25-(OH)D 3 level is a predictor for ICU admission and SAP independent of traditional risk factors for SAP. To our knowledge, this is the first study to reveal an independent association between vitamin D status and severity of AP. AP involves an initial inflammatory reaction within the pancreas. Subsequently, inflammatory cytokines induce hepatic synthesis of acute-phase proteins and mediate distant OF in the setting of SAP. Considering the known relationship between 25-(OH)D 3 and acute inflammation, 20 several recent studies have demonstrated that serum vitamin D levels were low in acute pancreatitis. Parrish et al. showed that up to 74.4% of their patients had blood 25-(OH)D 3 level less than 20 ng/ml, and approximately 34% of their patients had severe vitamin D deficiency with blood 25-(OH)D 3 levels less than 10 ng/ml. 21 Similarly, Bang et al. found that up to 40% of patients with AP had severe vitamin D deficiency at the time of admission. 18 However, these previous studies did not investigate the association between vitamin D deficiency and prognosis of AP. Although the independent role of vitamin D in the immunologic and inflammatory processes is well known, there have been few studies to investigate the association between vitamin D deficiency and prognosis of AP.
In the current study, we observed that vitamin D deficiency is closely associated with ICU admission 23 Bang et al. found that the blood level of 25-(OH)D 3 significantly and progressively decreased in a linear fashion from day 0 to day 2 in patients with AP. This decrease was associated with increasing CRP concentration in the blood. 18 Similarly, our study also demonstrated that CRP was negatively associated with serum 25-(OH)D 3 level, indicating that the AP inflammatory condition is intimately associated with a significant reduction in the serum 25-(OH)D 3 level. Therefore, it is reasonable to consider both 25-(OH)D 3 and 1,25-(OH) 2 D 3 as negative acute-phase reactants, specifically in the context of AP of various etiologies. In addition, a decrease of ionized calcium in patients with SAP increases the secretion of parathyroid hormone, which increases the nephrogenic metabolism of 25-(OH)D 3 24 . The current study has several limitations, the first of which is the study design. Although this study had a prospective design, there is a possibility of selection bias. All study participants were identified from one hospital, and most patients were older adults. Therefore, the individuals included in our study may have been more likely to be vitamin D deficient. In addition, the more severe patients were transferred to our university hospital, and patients with a higher risk for SAP were included in our study group. Another limitation was that serum 25-(OH)D 3 levels were measured only one time during various seasons. Furthermore, we did not collect data on sunlight exposure and types of food intake, which can affect serum 25-(OH)D 3 levels. Third, given the cross-sectional study design, a causal relationship of vitamin D in AP could not be disclosed. Lastly, the long-term outcomes of AP were not evaluated according to the serum 25-(OH)D 3 levels. Nevertheless, the results of our study have useful clinical implications in suggesting that, in addition to other known predictive factors such as CRP, diabetes and BMI, vitamin D deficiency might be considered as an independent risk factor for predicting the outcome of SAP. In addition, vitamin D is a convenient and simple biomarker for predicting SAP. Furthermore, this is the first study to extensively investigate the potential impact of vitamin D on the clinical outcomes of AP.
In conclusion, we demonstrated that lower blood vitamin D is a risk factor for ICU admission and severity of disease in patients with AP. This finding suggests that vitamin D status in individuals might be helpful to predict the prognosis of AP. Further prospective cohort or randomized trials are warranted to confirm our findings and to gain in-depth insight into the role of vitamin D in AP prognosis.
Declaration of conflicting interests
None declared. Ethics approval
